Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 25/11/20201 min de lecture
Termination of the Food and Drug Administration's Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective
Traduction automatique locale · Langue originale de la source
Résumé
The Department of Health and Human Services is issuing this Notice to withdraw FDA's Marketed Unapproved Drugs--Compliance Policy Guide, Sec. 440.100, Marketed New Drugs Without Approved NDAs or ANDAs, and to request information from the public regarding drugs that may be grandfathered or generally recognized as safe and effective.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →